EcoDrugPlus

Spleen Tyrosine Kinase

Ensembl ID : ENSMSIG00000007089
Gene Symbol: SYK
1 Cross references
215 Possible Orthologues:

Steroid 5 Alpha-Reductase 2

Ensembl ID : ENSMSIG00000022711
Gene Symbol: SRD5A2
1 Cross references
278 Possible Orthologues:

Sterol O-Acyltransferase 1

Ensembl ID : ENSMSIG00000014766
Gene Symbol: SOAT1
1 Cross references
225 Possible Orthologues:

Sucrase Isomaltase (Alpha-Glucosidase)

Ensembl ID : ENSMSIG00000024177
Gene Symbol: SIS
1 Cross references
212 Possible Orthologues:

Synuclein, Alpha

Ensembl ID : ENSMSIG00000023664
Gene Symbol: SNCA
1 Cross references
204 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSMSIG00000021757
Gene Symbol: TACR1
1 Cross references
282 Possible Orthologues:

Tachykinin Receptor 2

Ensembl ID : ENSMSIG00000030536
Gene Symbol: TACR2
1 Cross references
214 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSMSIG00000027174
Gene Symbol: TACR3
1 Cross references
271 Possible Orthologues:

Telomerase Reverse Transcriptase

Ensembl ID : ENSMSIG00000016999
Gene Symbol: TERT
1 Cross references
204 Possible Orthologues:

Thromboxane A Synthase 1, Platelet

Ensembl ID : ENSMSIG00000003914
Gene Symbol: TBXAS1
1 Cross references
234 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSMSIG00000024021
Gene Symbol: TBXA2R
1 Cross references
207 Possible Orthologues:

Thymidine Phosphorylase

Ensembl ID : ENSMSIG00000022545
Gene Symbol: TYMP
1 Cross references
188 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).